| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.29 | 0.06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |